2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T72653 | (R)-Elsubrutinib | (R)-ABBV-105 | |
(R)-Elsubrutinib ((R)-ABBV-105), a Btk inhibitor, is employed in research related to immune disorders (including rheumatoid arthritis, psoriasis, ankylosing spondylitis, asthma, systemic lupus erythematosus) and cancer. | |||
T39130 | Elsubrutinib | ABBV-105 | |
Elsubrutinib (ABBV-105) is a highly active, potent, and selective orally-administered inhibitor of Bruton's tyrosine kinase (BTK). It irreversibly inhibits the catalytic domain of BTK with an IC50 value of 0.18 μM. Elsub... |